HutchMed to Raise $600 Million in Hong Kong IPO

Shanghai 's HutchMed (formerly Hutchison Chi-Med) is planning to raise $600 million in a Hong Kong IPO. HutchMed has launched two novel oncology drugs in China , and it has eight more candidates in development. The Hong Kong IPO is the third listing for the company, following its first on London 's AIM exchange and then NASDAQ in the US . The company has a $4.3 billion market cap on NASDAQ. Cornerstone investors have agreed to purchase $325 million (54%) of the offered shares. HutchMed will set the purchase price on June 23. More details.... Stock Symbols: (NSDQ/AIM: HCM) Share this with colleagues: // //
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.